top of page
  • Active, not recruiting

NCT03539744: Phase 3 - A Study of Venetoclax/Dex Compared With Pomalidomide/Dex - t(11;14) +ive RRMM

Updated: Feb 10

  • CANOVA TRIAL

  • t(11;14)-positive Relapsed or Refractory Multiple Myeloma.


Canova Trial - t11:14

A Study of Venetoclax and Dexamethasone Compared With Pomalidomide and Dexamethasone in Participants With Relapsed or Refractory Multiple Myeloma


A study designed to evaluate the safety and efficacy of venetoclax plus dexamethasone (VenDex) compared with pomalidomide plus dexamethasone (PomDex) in participants with t(11;14)-positive Relapsed or Refractory Multiple Myeloma.


Sponsor

AbbVie


Collaborator

Roche-Genentech


Multiple locations

International Study

 

ClinicalTrials.gov Identifier: NCT03539744


Official Title: A Phase 3, Multicenter, Randomized, Open Label Study of Venetoclax and Dexamethasone Compared With Pomalidomide and Dexamethasone in Subjects With t(11;14)-Positive Relapsed or Refractory Multiple Myeloma


First Posted : May 29, 2018


Click here for details on ClinicalTrials.gov

 


 

Drug: Pomalidomide

Drug: Dexamethasone

Drug: Venetoclax

 

Locations

United States, Arizona

United States, California

United States, Colorado

United States, Florida

United States, Kentucky

United States, Maryland

United States, Massachusetts

United States, Michigan

United States, Minnesota

United States, New York

United States, Ohio

United States, Pennsylvania

United States, Texas

United States, Utah

United States, Washington


Australia, New South Wales

Australia, Queensland

Australia, South Australia

Australia, Western Australia


Canada, Alberta

Canada, British Columbia

Canada, Nova Scotia

Canada, Quebec


China

China, Beijing

China, Guangdong

China, Henan

China, Hubei

China, Jiangsu

China, Jiangxi

China, Liaoning

China, Shanghai

China, Tianjin

China, Zhejiang


Europe

United Kingdom

France

Germany

Italy

Spain

Czechia

Denmark

Greece

Sweden

Turkey

Ukraine


Asia

Israel

Japan

Korea, Republic of

Russian Federation

Singapore










Posts Archive
bottom of page